Meritain Health policies
Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
7 policies name J9100, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0921-Daunorubicin-Cytarabine Liposome (Vyxeos) | 0921 · Commercial | 4 | Original policy ↗ |
| 0922-Gemtuzumab Ozogamicin (Mylotarg) | 0922 · Commercial | 5 | Original policy ↗ |
| 0919-Inotuzumab Ozogamicin (Besponsa) | 0919 · Commercial | 22 | Original policy ↗ |
| 0795-Dexamethasone Ophthalmic Implant (Ozurdex) and Insert (Dextenza) | 0795 · Commercial | 31 | Original policy ↗ |
| 0875-Bendamustine Products | 0875 · Commercial | 34 | Original policy ↗ |
| Hematopoietic Colony-Stimulating Factors (CSFs) | 0055 · Commercial | 91 | Original policy ↗ |
| Antiemetic Therapy | 0724 · Commercial | 152 | Original policy ↗ |